- Home
- NXL vs ANGH Comparison
NXL vs ANGH Comparison
Compare NXL & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXL | ANGH |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United Arab Emirates |
| Employees | 7 | N/A |
| Industry | Medical Specialities | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1M | 19.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | NXL | ANGH |
|---|---|---|
| Price | $1.08 | $2.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 261.4K | 4.0K |
| Earning Date | 11-14-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $156,931.00 | ★ $78,093,405.00 |
| Revenue This Year | $38.28 | N/A |
| Revenue Next Year | $185.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 88.72 |
| 52 Week Low | $0.70 | $2.53 |
| 52 Week High | $4.49 | $9.40 |
Technical Indicators
Market Signals| Indicator | NXL | ANGH |
|---|---|---|
| Relative Strength Index (RSI) | 42.46 | 49.72 |
| Support Level | $0.93 | $2.85 |
| Resistance Level | $1.12 | $2.94 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 35.20 | 59.53 |
Price Performance
Historical ComparisonAbout NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.